Fondaparinux Sodium Injection, Solution
Product Images NDC 67457-583

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Fondaparinux Sodium (NDC 67457-583). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 And 2 (Image 01)

Figure 1 And 2 (Image 01)
FDA Label Image

Figure 3 And 4 (Image 02)

Figure 3 And 4 (Image 02)
FDA Label Image

Fondaparinux Sodium Structural Formula (Image 03)

Fondaparinux Sodium Structural Formula (Image 03)
FDA Label Image

Arixtra-syringe-1 (Image 04)

Arixtra-syringe-1 (Image 04)
FDA Label Image

Arixtra-syringe-2 (Image 05)

Arixtra-syringe-2 (Image 05)
FDA Label Image

Arixtra-syringe-3 (Image 06)

Arixtra-syringe-3 (Image 06)
FDA Label Image

Arixtra-figure-a (Image 07)

Arixtra-figure-a (Image 07)
FDA Label Image

Arixtra-figure-b (Image 08)

Arixtra-figure-b (Image 08)
FDA Label Image

Arixtra-figure-c (Image 09)

Arixtra-figure-c (Image 09)
FDA Label Image

Arixtra-figure-d (Image 10)

Arixtra-figure-d (Image 10)
FDA Label Image

Arixtra-figure-e (Image 11)

Arixtra-figure-e (Image 11)
FDA Label Image

Arixtra-figure-f (Image 12)

Arixtra-figure-f (Image 12)
FDA Label Image

Fondaparinux Sodium Injection, Usp For Subcutaneous Injection 5 mg/0.4 mL Carton Label (Image 13)

Fondaparinux Sodium Injection, Usp For Subcutaneous Injection 5 mg/0.4 mL Carton Label (Image 13)
This is a description of a pharmaceutical product known as Fondaparinux Sodium Injection, USP used for Subcutaneous Injection. The product comes in a pack containing 10 single-dose, prefilled syringes for Rxonly which are affixed with an automatic needle protection system. The pharmacist is advised to dispense the accompanying patient information leaflot to each patient.*
FDA Label Image

Fondaparinux Sodium Injection, Usp For Subcutaneous Injection 7.5 mg/0.6 mL Carton Label (Image 14)

Fondaparinux Sodium Injection, Usp For Subcutaneous Injection 7.5 mg/0.6 mL Carton Label (Image 14)
FDA Label Image

Fondaparinux Sodium Injection, Usp For Subcutaneous Injection 10 mg/0.8 mL Carton Label (Image 15)

Fondaparinux Sodium Injection, Usp For Subcutaneous Injection 10 mg/0.8 mL Carton Label (Image 15)
This is a description of a drug called Fondaparinux Sodium Injection, USP. The drug comes in pre-filled syringes containing 75mg/0.6ml of the drug and is for subcutaneous injection only. The box contains ten single-dose syringes and is affixed with an automatic needle protection system. Additionally, the pharmacist is directed to dispense the patient information leaflet for each patient. The NDC number for the drug is 67457-584-06.*
FDA Label Image

Image 16

Image 16
Fondaparinux Sodium Injection is a medicine that is administered via subcutaneous injection. The medication is packaged in 10 pre-filled single-dose syringes, each with an automatic needle protection system. The package comes with a patient information leaflet, which should be dispensed to each patient. The rest of the text appears to be illegible.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.